Lophos Pharma

"Over 131 million people in the United States, that’s over 66% of the population, are currently prescribed to a prescription medication," said Courtney Barnes, a partner at a New York-based cannabis and psychedelics law firm Feldman Legal Advisors. "Of those prescription medications available...

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Claire Stawnyczy, CEO of Lophos Pharmaceuticals Corp. was a guest speaker at Benzinga’s Psychedelics Capital Conference on April 19, 2022.  Lophos...

Greenridez 2.0 Acquisitions Corp. confirmed Friday that it has completed its acquisition of psychedelic research company Lophos Pharma, which is primarily concentrated on new therapeutic treatments derived from Peyote (Lophophora williamsii). The Toronto-based company confirmed that it...